7 Things Every Indian With Sickle Cell Trait Should Know About Their Health
You are a carrier, not a patient, but the distinction has limits
Sickle cell trait means you inherited one copy of the HbS gene and one normal copy. Your body produces both haemoglobin A and haemoglobin S. Under ordinary conditions, you will not have a sickle cell crisis. The Indian Council of Medical Research estimates that roughly 1 in 86 Indians carries the sickle cell trait, with prevalence concentrated in tribal populations across Odisha, Chhattisgarh, Madhya Pradesh, Maharashtra, and parts of Gujarat and Jharkhand. That is not a small number. Most of these individuals were never told they carry the gene.
The carrier status protects you from the full severity of sickle cell disease, but it does not make the gene inert. Under conditions of extreme physical stress, severe dehydration, very high altitude, intense anaerobic exertion, your HbS haemoglobin can sickle. The sickling is usually reversible and does not trigger a full crisis, but it is real and it has clinical consequences.
Extreme exertion is a specific, documented risk
A 2012 study published in the British Journal of Sports Medicine found that military recruits with sickle cell trait had a significantly higher risk of exertional rhabdomyolysis, a breakdown of muscle tissue that can cause acute kidney injury, compared to recruits without the trait. The US Army now screens for the trait precisely because of this risk during high-intensity training in heat.
For Indian carriers, this matters in two specific contexts: competitive athletics with sustained anaerobic effort, and manual labour in extreme heat without adequate hydration. The risk is not theoretical. Staying well-hydrated, avoiding sudden spikes in exertion intensity, and informing coaches or trainers about the trait are practical steps that reduce it meaningfully.
Your children's health depends on your partner's genetic status
If both parents carry sickle cell trait, each pregnancy carries a 25% chance of producing a child with sickle cell disease, a 50% chance of another carrier, and a 25% chance of neither. Sickle cell disease, two copies of HbS, causes severe anaemia, organ damage, and a significantly shortened lifespan without aggressive medical management.
Pre-marital and pre-conception genetic screening is now part of the National Sickle Cell Anaemia Elimination Mission, which the Indian government launched with a target of eliminating the disease by 2047. State governments in Odisha, Chhattisgarh, and Maharashtra have been running screening camps in tribal districts for years. If you know you carry the trait, your partner should be tested before you plan a pregnancy. A genetic counsellor can walk you through the specific probabilities and the available options, including prenatal diagnosis.
Anaemia in carriers is usually mild, but not always the trait's fault
Most people with sickle cell trait have a normal or near-normal haemoglobin count. The trait alone does not cause the chronic haemolytic anaemia seen in sickle cell disease. If you have been told you are anaemic and you carry the trait, the two are probably not connected, iron deficiency anaemia is far more common in India and the more likely explanation.
A complete blood count with haemoglobin electrophoresis will distinguish between the two. Iron supplementation will not correct a haemoglobin problem caused by sickle cell disease, and indiscriminate iron supplementation in someone who is not actually iron-deficient carries its own risks. Getting the right test matters more than starting the most common treatment.
Altitude and dehydration are the two conditions to plan around
At altitudes above roughly 2,500 metres, blood oxygen saturation drops enough that HbS haemoglobin in carriers can begin to sickle. Reports of splenic infarction, death of splenic tissue due to sickling, in otherwise healthy carriers at high altitude have appeared in medical literature since the 1960s. The spleen is particularly vulnerable because it traps and filters red blood cells.
Trekking in Ladakh, Spiti, or the higher Himalayan routes is not automatically off-limits for a carrier, but it requires preparation: gradual acclimatisation, aggressive hydration, and awareness of symptoms like sudden left-sided abdominal pain, which can indicate splenic involvement. Informing the trek organiser and carrying a card that states your carrier status is basic preparation, not overcaution.
Your haemoglobin electrophoresis result is the only definitive test
A standard complete blood count will not tell you whether you carry the sickle cell trait. The red cells of a carrier look normal under routine microscopy. Haemoglobin electrophoresis, or the newer high-performance liquid chromatography method, which most large Indian labs now offer, separates haemoglobin variants and shows the proportion of HbA to HbS. A carrier typically shows roughly 35 to 45% HbS and the remainder HbA.
Many Indians in high-prevalence communities have never had this test. If you have a family history of sickle cell disease, or if you are from a community in central or western India where the trait is common, asking for an HPLC haemoglobin test at your next blood draw costs very little and provides information that is relevant for the rest of your life.
Surgical and anaesthetic teams need to know
Before any surgery requiring general anaesthesia, your carrier status is clinically relevant. Anaesthesia can cause drops in blood oxygen, and certain surgical positions or tourniquet techniques reduce local oxygen delivery. Most anaesthetists will not ask specifically about sickle cell trait if you do not volunteer it, because the trait is not part of routine pre-operative screening in most Indian hospitals.
Telling your surgeon and anaesthetist before the procedure allows them to take precautions: maintaining oxygenation, avoiding prolonged tourniquet use, and ensuring adequate hydration through the procedure. This is not about refusing surgery, it is about giving the medical team information they can act on.
The trait's silence is its defining feature and its main hazard. It produces no symptoms in daily life, which means most carriers never seek a diagnosis, never tell their partners, and never tell their doctors. The gene travels quietly through families for generations while the disease it can produce, when two carriers have children together, is anything but quiet. Knowing you carry it does not change your daily health. It changes what you owe the people around you, and what you owe yourself in the specific situations where the trait stops being silent.